I Koza

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients

Ian E. Smith, Jean‐Yves Pierga, Laura Biganzoli et al. · Annals of Oncology · 2010 · 104 citations · Full text

Medicine, Oncology, Pharmacology +14

Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study.

Jozef Mardiak, Tomáš Šálek, Zuzana Syčová-Milá et al. · PubMed · 2005 · 48 citations

Medicine, Oncology, Pharmacology +16

Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study

Michal Mego, R. Končeková, Eva Ballová Mikušková et al. · Supportive Care in Cancer · 2005 · 37 citations

Life Sciences, Microbiology, Oncology +13

Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I.

Michal Mego, L. Ebringer, Ľuboš Drgoňa et al. · PubMed · 2005 · 28 citations

Medicine, Oncology, Pharmacology +13

Adjuvant clodronate therapy in patients with locally advanced breast cancer--long term results of a double blind randomized trial. Slovak Clodronate Collaborative Group.

Jozef Mardiak, L Bohunický, Josef Chovanec et al. · PubMed · 2000 · 18 citations

Medicine, Oncology, Pharmacotherapy +14